Abstract

Simple SummaryPrimary bone cancers like osteosarcoma (OS) are driven by bone cells that develop mutations, and behave in an uncontrolled manner. All bone cells, including defective ones, are sensitive to their physical environment. We tested the response of osteosarcoma cells, at the gene level, to two different kinds of mechanical stimulus, which are relevant to the tumor microenvironment. The first was fluid flowing over their surface, and the second was stiffness or rigidity of the surface beneath. In our study we found that fluid flow in particular has the ability to change the behavior of OS cancer cells, and could potentially be used to reduce their harmful effects. Osteosarcoma (OS) is an aggressive bone cancer originating in the mesenchymal lineage. Prognosis for metastatic disease is poor, with a mortality rate of approximately 40%; OS is an aggressive disease for which new treatments are needed. All bone cells are sensitive to their mechanical/physical surroundings and changes in these surroundings can affect their behavior. However, it is not well understood how OS cells specifically respond to fluid movement, or substrate stiffness—two stimuli of relevance in the tumor microenvironment. We used cells from spontaneous OS tumors in a mouse engineered to have a bone-specific knockout of pRb-1 and p53 in the osteoblast lineage. We silenced Sox2 (which regulates YAP) and tested the effect of fluid flow shear stress (FFSS) and substrate stiffness on YAP expression/activity—which was significantly reduced by loss of Sox2, but that effect was reversed by FFSS but not by substrate stiffness. Osteogenic gene expression was also reduced in the absence of Sox2 but again this was reversed by FFSS and remained largely unaffected by substrate stiffness. Thus we described the effect of two distinct stimuli on the mechanosensory and osteogenic profiles of OS cells. Taken together, these data suggest that modulation of fluid movement through, or stiffness levels within, OS tumors could represent a novel consideration in the development of new treatments to prevent their progression.

Highlights

  • Osteosarcoma (OS) is an aggressive bone cancer that originates in the osteoblast lineage and is the most common primary bone malignancy worldwide

  • The effect of substrate stiffness on cell proliferation showed that increased stiffness resulted in increased cell proliferation in scr cells, but this effect was diminished in the absence of Sox2 (Figure 4D)

  • The expression levels of downstream targets of Yes-Associated Protein (YAP) (CYR61, connective tissue growth factor (CTGF) and BDNF) were assessed to determine its intracellular activity, in addition to location, which was unchanged by substrate stiffness in both cell groups (Figure 5C)

Read more

Summary

Introduction

Osteosarcoma (OS) is an aggressive bone cancer that originates in the osteoblast lineage and is the most common primary bone malignancy worldwide. OS tumors normally develop during growth phases in children, adolescents and young adults [1]. OS develops as a solid tumor which forms at the metaphyseal growth plate of long bones in the appendicular skeleton. The annual occurrence rate of OS is less than 10 per million in the USA. OS has a high rate of metastasis, and 90% of metastases are found in the lungs [1]. Prognosis for metastatic disease is generally poor, and with a mortality rate of approximately 40%, OS is an extremely aggressive disease for which new treatments are needed [3,4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call